medicaid approved glp 1 covers GLP-1 meds for obesity in just 13 states, analysis finds Trump won't force Medicaid to

Largest pharmacoepidemiologic study of analgesic prescribing trends in cirrhosis, demonstrating declining opioid and rising nonopioid prescribing over an 11-year period in a national longitudinal cohort

Soluble in: Bacteriostatic water

Opioid use may worsen gastric retention Higher prevalence of recent opioid use in the high RGC group Suggests an additive effect on gastric motility No difference in indication or duration of therapy Whether patients used GLP-1 RAs for diabetes or weight loss did not affect risk Duration of therapy was not a significant predictor Interpretation Withholding 7.5 days higher risk of retained gastric contents Fasting 21.3 hours strongest predictor of high RGC These thresholds optimize sensitivity and specificity for detecting risk

Terrill SJ, Maske CB, Williams DL